SecondOpinion
An overlay for clinicians using AI diagnostic and triage assistants that surfaces per-recommendation confidence, flags the uncertain ones in red, and explains which clinical signals the AI leaned on most.
Physicians and nurse practitioners using AI co-pilots for triage, imaging, or chart summarization
- Per-recommendation confidence score with plain-language rationale ('uncertain because lab value borderline, prior history missing')
- Red-flag queue that surfaces only the cases where AI confidence falls below a clinician-set threshold
- One-click 'show your work' view of the inputs the model weighted most heavily
- Audit log exported to EHR for medico-legal review of AI-influenced decisions
Majority of enterprise AI agent failures are now attributed to context drift and provenance loss, and clinical settings are the highest-stakes deployment of those agents.
CDSS market is sizable and growing: Mordor projects $0.87B in 2025 growing at 15.6% CAGR, Global Growth Insights reports 65%+ hospital CDSS adoption; ambient AI scribes already mainstream among physicians, creating an installed base that could plausibly adopt an explainability overlay.AI-powered Clinical Decision Support Market Size & Share Analysis ↗Clinical Decision Support System Market Growth Trends | 9.3% CAGR Forecast ↗
The primary scribe/co-pilot layer is crowded (Abridge, Nuance DAX, Suki, Nabla, DeepScribe, Freed), but a vendor-agnostic confidence-and-provenance overlay is differentiated; however, incumbents are adding their own explainability features (MDPI notes calibration/transparency gaps in DSS), so window is real but narrowing.MedSync vs Nuance DAX vs Suki vs Abridge: feature-by-feature comparison ↗Enhancing Clinician Trust in AI Diagnostics: A Dynamic Framework for Confidence Calibration ↗
Healthcare AI tools command $200–$1,000+ per provider/month and hospitals budget for risk/compliance, but a thin overlay layer is harder to monetize as a standalone SKU — likely needs to bundle or sell to enterprise risk/compliance buyers rather than per-seat clinicians, creating friction.Best AI Medical Scribe Software: Top 10 Solutions Compared (2025) ↗
Explainability is a regulatory and ethical durability driver: EU AI Act classifies medical AI as high-risk requiring transparency, FDA post-market guidance increasingly emphasizes human-interpretable outputs, and peer-reviewed work (Tandfonline, PMC meta-analysis) frames explainability as central to adoption — multi-year tailwinds are strong.Explainability and AI Confidence in Clinical Decision Support Systems ↗Explainable AI in Clinical Decision Support Systems: A Meta-Analysis ↗
Requires Epic/Cerner integration (or vendor partnerships), clinical validation, and likely FDA SaMD scoping — nontrivial given EHR access politics and the need to intercept or mirror outputs of upstream AI tools; execution risk is high even if the technical core is tractable.Improving Explainability and Integrability of Medical AI to Promote Adoption ↗